Overview

Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
An investigation on the cumulative skin irritation potential of a newly developed 15 mg nicotine patch. Evaluation of skin irritation of a newly developed 15 mg nicotine transdermal patch.
Phase:
Phase 1
Details
Lead Sponsor:
McNeil AB
Treatments:
Nicotine